Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059626) titled 'The Effect of Physical Activity on Postoperative Outcomes in Renal Transplant Patients' on Nov. 10.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - Shonan Kamakura General Hospital(Clinical Research Center)

Condition: Condition - Chronic Kidney Disease Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To measure Physical activity levels during hospitalization in kidney transplant patients using wearable devices and clarify the impact of activity levels on physical function at discharge and the occurrence of postoperative complications. Basic objectives2 - Others

Intervention: Interventions/Control_1 - Attach the device to the waist to measure activity levels. The patients wear it the day after surgery and keep it on at all times except during sleep and bathing. The wearing period is 10 days starting the day after surgery. Postoperatively, standard rehabilitation interventions will be implemented for all subjects.

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1) Hospitalized patients undergoing Renal transplantation at our institution (regardless of underlying disease or prior dialysis history) 2) Patients aged 20 years or older at the time of consent acquisition (gender not restricted) (Note the subject's age when evaluating the IPAQ) 3) Research subjects who, after receiving sufficient explanation regarding participation in this study, provided written informed consent of their own free will Key exclusion criteria - Patients meeting any of the following criteria shall not be included in this study: 1) Patients with a history of myocardial infarction 2) Patients with a history of coronary revascularization (PCI or CABG) 3) Patients with concomitant unstable angina 4) Patients with a history of cerebrovascular disease (excluding asymptomatic lacunar infarction) 5) Patients with a history of hospitalization due to heart failure 6) Patients with severe liver disease (AST (GOT) or ALT (GPT) 100U or more) 7) Women who are pregnant or may be pregnant 8) Women who are breastfeeding 9) Other patients deemed unsuitable as study subjects by the principal investigator. Target Size - 70

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 06 Month 09 Day Anticipated trial start date - 2025 Year 11 Month 10 Day Last follow-up date - 2028 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068200

Disclaimer: Curated by HT Syndication.